Tactical and Strategic Use of AI in the Planning, Evaluation, and Reporting of Clinical Trials | 09

Episode Summary

In this episode of the Verisian Community Podcast, Richardus Vonk discusses the transformative role of AI in clinical trials. He explores how AI is reshaping trial planning and execution, improving early disease detection like cancer, and the challenges it still faces in drug development. Richardus also highlights the benefits of automation in freeing up time for deeper scientific exploration and elaborates on the tactical versus strategic use of AI and GenAI. The conversation touches on the rise of open-source tools, balancing data sharing with patient privacy, while offering a vision for the future of clinical trials over the next decade.

About The Verisian Community Podcast

The Verisian Community Podcast brings together experts in clinical trials to exchange innovative ideas and best practices central to clinical reporting, submission and review. Aligned with Verisian's mission to accelerate the evaluation and market launch of new medical treatments, each episode features expert insights, with guests ranging from statistical programmers to medical writers, to discuss the challenges and opportunities of the latest software and technology.

You can listen to us on Apple Podcasts or Spotify.

Resources

• Learn about the Validation Engine: https://www.verisian.com/‍
• Join the Verisian Community: https://www.verisian.com/community/
• Follow us on LinkedIn: https://www.linkedin.com/company/verisian/